Risk prediction of hepatocellular carcinoma in patients with cirrhosis: the ADRESS-HCC risk model
about
Surveillance of Hepatocellular Carcinoma and Diagnostic Algorithms in Patients with Liver CirrhosisMolecular prognostic prediction in liver cirrhosisSeverity of liver cirrhosis: a key role in the selection of surgical modality for Child-Pugh A hepatocellular carcinomaInfrared spectroscopic imaging detects chemical modifications in liver fibrosis due to diabetes and diseaseShort-term and long-term efficacy of 7 targeted therapies for the treatment of advanced hepatocellular carcinoma: a network meta-analysis: Efficacy of 7 targeted therapies for AHCC.Screening and surveillance for hepatocellular carcinoma: perspective of a new era?Screening for hepatocellular carcinoma: patient selection and perspectivesRisk prediction models for hepatocellular carcinoma in different populations.Domain Analysis of Integrated Data to Reduce Cost Associated with Liver Disease.Screening for hepatocellular carcinoma and cholangiocarcinoma: Can biomarkers replace imaging?Diabetes and Hepatitis C: A Two-Way Association.Associations between single-nucleotide polymorphisms of human exonuclease 1 and the risk of hepatocellular carcinoma.Validation of a Risk Estimation of Tumor Recurrence After Transplant (RETREAT) Score for Hepatocellular Carcinoma Recurrence After Liver Transplant.Eradication of hepatitis C virus and non-liver-related non-acquired immune deficiency syndrome-related events in human immunodeficiency virus/hepatitis C virus coinfection.Tailored algorithms for hepatocellular carcinoma surveillance: Is one-size-fits-all strategy outdated?Percutaneous radiofrequency ablation of hepatocellular carcinoma in cirrhosis: analysis of complications in a single centre over 20 years.Surveillance of the Patients with High Risk of Hepatocellular Cancer.HbA1c-Based Score Model for Predicting Death Risk in Patients with Hepatocellular Carcinoma and Type 2 Diabetes Mellitus.Reduction in liver transplant wait-listing in the era of direct-acting antiviral therapy.Diabetes Mellitus Heightens the Risk of Hepatocellular Carcinoma Except in Patients With Hepatitis C Cirrhosis.Circulating Osteopontin and Prediction of Hepatocellular Carcinoma Development in a Large European Population.Risk factors and prevention of hepatocellular carcinoma in the era of precision medicine.Misdiagnosis of hepatocellular carcinoma in patients receiving no local-regional therapy prior to liver transplant: An analysis of the Organ Procurement and Transplantation Network explant pathology form.The 6th Asia-Pacific Primary Liver Cancer Expert Meeting (APPLE 2015): Evidence and Consensus on HCC Management.Risk Assessment of Hepatocellular Carcinoma in Patients with Hepatitis C in China and the USA.Liver volume-based prediction model stratifies risks for hepatocellular carcinoma in chronic hepatitis B patients on surveillance.Screening for hepatocellular carcinoma: What is missing?
P2860
Q26740317-6665A424-A992-4838-A9D8-9E61AF75E047Q26784251-0714FEB1-4DF1-48A1-B107-837C17A1986FQ27013963-57C0A833-B72D-47D3-A70C-EA12508017E8Q28829194-D31DDE83-E3A1-4058-86F8-C523A19655C1Q30240170-2302B58E-21BA-4BD2-A747-228348A3AD68Q30244651-73A46EC5-8CFB-45C1-BCBF-3F6F41A05B4EQ30355713-064FE7C0-666F-4A58-8447-49EA92A44C90Q30383460-A2123B7D-B9DE-44E7-911B-0479A7B5E881Q30986369-F168C27C-E1D4-47B2-A5D5-A187D14AF6BBQ36000994-77EE5C81-648C-4A3A-935C-5695AB58FA9FQ36056076-FF0C079F-8DB1-4A46-8824-65FD1EA3C26BQ37699397-071B5811-0F2C-4244-93FF-8EDB41FE0637Q38795885-ECFFA758-9E0C-4A5A-A21F-1FD36DA99E3DQ39008634-C794B30A-B186-4C16-9D73-D605F5F918AAQ39197775-9FDEF97C-270E-4C14-B35F-16D3AA72ADE2Q39237369-62FD0787-8D39-4388-940B-6784F95345E4Q39387245-E7D32446-10AB-4171-AE24-2DE81120F725Q40347780-EDB1CEE4-7E3E-44F2-AA35-70018C7B56A0Q40409092-46CB997E-B0F1-4654-83C2-2EBE5D3CEC0FQ40469321-E981FE29-DC5C-4887-9776-3DDA46F90673Q40684396-AFFE85CD-748E-4A68-A664-B9A139DB5D81Q41921861-0669A651-D408-405F-B959-E356A8285751Q42688811-F6CBA5D0-FF0A-4516-8D4E-335173F052D1Q46027563-76F1390C-0A33-44DE-8A5C-5934C8FE5079Q47631237-7ED2671B-70B8-4AC2-83ED-E44935873CECQ47756206-D550127C-C56A-4C88-9673-A8BEB4618E74Q54468930-39A5F628-B479-4A85-9CC6-149EB1FE1A73
P2860
Risk prediction of hepatocellular carcinoma in patients with cirrhosis: the ADRESS-HCC risk model
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Risk prediction of hepatocellu ...... sis: the ADRESS-HCC risk model
@ast
Risk prediction of hepatocellu ...... sis: the ADRESS-HCC risk model
@en
type
label
Risk prediction of hepatocellu ...... sis: the ADRESS-HCC risk model
@ast
Risk prediction of hepatocellu ...... sis: the ADRESS-HCC risk model
@en
prefLabel
Risk prediction of hepatocellu ...... sis: the ADRESS-HCC risk model
@ast
Risk prediction of hepatocellu ...... sis: the ADRESS-HCC risk model
@en
P2093
P2860
P356
P1433
P1476
Risk prediction of hepatocellu ...... sis: the ADRESS-HCC risk model
@en
P2093
Jennifer A Flemming
Ju Dong Yang
Norah A Terrault
P2860
P304
P356
10.1002/CNCR.28832
P407
P577
2014-07-16T00:00:00Z